AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Total-Stockholder-Equity" stands at 45.97 Billion United States Dollars as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.
As of the end of AstraZeneca PLC's third quarter, the item "Total Stockholder Equity" stands at 45.97 Billion USD. This represents an increase of 2.59 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 12.66 percent compared to the value the year prior.
The 1 year change in percent is 12.66.
The 3 year change in percent is 30.77.
The 5 year change in percent is 237.58.
The 10 year change in percent is 164.69.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Stockholder Equity | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Stockholder Equity | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Stockholder Equity | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Stockholder Equity | 317,433,206,677.55 |
![]() | Novartis AG - Total Stockholder Equity | 255,096,620,580.91 |